Financial statements Interpharm

Balance sheet of Interpharm

Company age:
Age:
14 y. 7 m. 8 d.
Share capital:
Share capital:
5 000 PLN

Balance sheet data of INTERPHARM

Year
2018
2019
2020
2021
2022
2023
Total assets 2 414,04 2 278,04 2 119,04 2 202,98 5 617,61 9 029,30
A. Fixed assets 0,00 0,00 0,00 0,00 0,00 0,00
B. Current assets 2 414,04 2 278,04 2 119,04 2 202,98 5 617,61 9 029,30
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 2 414,04 2 278,04 2 119,04 2 202,98 5 617,61 9 029,30
A. Equity 387,05 251,05 79,05 -396,01 -7 160,96 -11 585,70
B. Liabilities and provisions for liabilities 2 026,99 2 026,99 2 039,99 2 598,99 12 778,57 20 615,00
I. Long-term liabilities - - - - - -
II. Short-term liabilities - - - - - -
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.

  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.